VF
IMMX icon

Virtu Financial’s Immix Biopharma IMMX Stock Holding History

Virtu Financial’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$438K Sell
48,109
-25,682
-35% -$189K 0.02% 622
2025
Q4 		$386K Buy
+73,791
New +$304K 0.02% 724
2025
Q3 		– Sell
-17,846
Closed -$37K – 1752
2025
Q2 		$37K Buy
+17,846
New +$35.9K ﹤0.01% 1179
2022
Q2 		– Sell
-23,515
Closed -$57K – 1795
2022
Q1 		$57K Buy
+23,515
New +$87.3K ﹤0.01% 1094

Other funds holding IMMX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Virtu Financial's IMMX Position: Q1 2026 in Review

Virtu Financial reduced its Immix Biopharma (IMMX) stake by 35% in Q1 2026, selling an estimated $189K and leaving 48,109 shares worth $438K. The position accounts for 0.02% of the portfolio, ranked #622.

Virtu Financial first reported a position in IMMX in Q1 2022 and has held it in 4 quarters since. 77 funds tracked by Wall St. Rank hold IMMX as of Q1 2026.

  • Virtu Financial held 48,109 shares of Immix Biopharma worth $438K as of Q1 2026.
  • Virtu Financial sold 25,682 Immix Biopharma shares in Q1 2026, an estimated $189K.
  • Immix Biopharma made up 0.02% of Virtu Financial's portfolio in Q1 2026, its #622 holding.
  • Virtu Financial first reported a position in Immix Biopharma in Q1 2022 and has held it in 4 quarters since.
  • 77 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.